On one hand, these medications can help you manage your blood sugar and lose weight, but on the other hand, they can come with some unpleasant side effects
Currently, there are more than 300 clinical trials for people living with T1D and T1D-related complications under way
The online consultations were convenient, and the doctor guided my lifestyle changes too
Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, shared these findings on Nov
Key Takeaways Retatrutide and tirzepatide target different combinations of metabolic receptors, influencing their effects on weight loss and glucose control
All drugs targeting GLP-1 receptors currently have the potential risk for pancreatitis, gallbladder disease, and gastrointestinal intolerance